インスリンリスプロミックス50/50療法の有効性

基本情報

NCT ID

NCT01303042

ステータス

不明

試験のフェーズ

該当なし

試験タイプ

介入

目標被験者数

80

治験依頼者名

Aichi Gakuin University

概要

Insulin therapy with lispro mix 50/50 t.i.d. is a treatment with a single insulin device. The management is comparatively simple and easy, but the curative effect is promising. It is also reported that noninferiority has been observed between basal/bolus therapy (BBT) and prandial premixed therapy (PPT, lispro mix 50/50 t.i.d.). The purpose of this study is to evaluate whether change of insulin therapy from BBT (long-acting insulin at bedtime plus mealtime rapid-acting insulin) or analog insulin therapy t.i.d. (including therapies with aspart mix 70/30 and lispro mix 75/25) to lispro mix 50/50 t.i.d. improves glycemic control of patients with type 2 diabetes mellitus.

対象疾患

介入

依頼者（Sponsor）

実施施設 (4)